drugset / Trial / NCT02089399

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

NCT02089399

Phase 1 Completed 32 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between amlodipine, olmesartan and rosuvastatin in healthy adult volunteers.

Timeline

Start
2014-05
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Olmesartan Other / unclassified
Subject Rosuvastatin Small molecule
Subject amlodipne Unknown

Indications

No indication recorded.